SCHEMBL9894847

SCHEMBL9894847

Cc1cc(C(=O)OC2CCC(c3ccccc3O)CC2)cc(C)c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 5/20 0.52
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
TYR P14679 1/20 0.41
SCN1A P35498 3/20 0.40
SCN2A Q99250 3/20 0.40
SCN3A Q9NY46 3/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
HCRTR2 O43614 1/20 0.37
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
CHRNA7 P36544 1/20 0.36
HTR3A P46098 1/20 0.36
HTR3D Q70Z44 1/20 0.36
HTR3C Q8WXA8 1/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9895337 0.89 TAS1R3 (0.46) SERPINE1KMT2AMEN1TYRSCN1A
SCHEMBL9895419 0.80 TYR (0.47) SERPINE1KMT2AMEN1TYRSCN1A
SCHEMBL9896453 0.79 SERPINE1 (0.43) SERPINE1KMT2AMEN1TYRSCN1A
SCHEMBL9894848 0.79 SERPINE1 (0.51) SERPINE1KMT2AMEN1SCN1ASCN2A
SCHEMBL6450371 0.75 TYR (0.49) SERPINE1KMT2AMEN1TYRSCN1A
SCHEMBL6450374 0.75 TYR (0.49) SERPINE1KMT2AMEN1TYRSCN1A
SCHEMBL6455408 0.72 SCN1A (0.56) SERPINE1KMT2AMEN1TYRSCN1A
SCHEMBL6455403 0.72 SCN1A (0.56) SERPINE1KMT2AMEN1TYRSCN1A
SCHEMBL9894704 0.71 TYR (0.45) SERPINE1TYRSCN1ASCN2ASCN3A
SCHEMBL13286821 0.70 SERPINE1 (1.00) SERPINE1CA1CA2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9242948-B2 Diepoxy compound, process for producing same, and composition containing the diepoxy compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-01-26 US disclosed
EP-2474539-B1 DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND SUMITOMO CHEMICAL CO (JP) 2013-11-27 EP disclosed
EP-2474539-A1 DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND Sumitomo Chemical Company, Limited (JP) 2012-07-11 EP disclosed
US-20120149807-A1 DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149807-A1 DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND DHPS, DOHH, CYP19A1 SERPINE1 4384/4885KMT2A 3154/4885MEN1 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.